Reminiscent of this subtype of AML in humans, these transgenic mice have normal chromosomal structures, reduced MLL-WT expression, loss of FLT3-WT, and increased total FLT3 expression [179,180,181,182]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.